Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ashby

Showing results (71-80 of 320) with videos related to

Pageof 32
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 3, 2015
The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decadeRishil J Kathawala, Pranav Gupta, Charles R Ashby, et al.
The Journal of Clinical Psychiatry|September 1, 1994
The role of 5-HT3-like receptors in the action of clozapineR Y Wang, C R Ashby, E Edwards, et al.
European Journal of Pharmacology|July 16, 1997
Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis studyA E Morgan, B Horan, S L Dewey, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 16, 2019
Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance HemodialysisAnamika Adwaney, Charlotte Lim, Sarah Blakey, et al.
Neuroscience|May 1, 1994
The induction of serotonin3-like receptor supersensitivity and dopamine receptor subsensitivity in the rat medial prefrontal cortex after the intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine: a microiontophoretic studyC R Ashby, J Y Zhang, E Edwards, et al.
Clinical Nephrology|March 28, 2022
Diagnostic value of pericardial aspiration in dialysis patients: Case report with management informed by a retrospective case seriesAmarpreet K Thind, Sophie Blackburn, Richard W Corbett, et al.
Medical Review (2021)|June 26, 2024
The delivery of N-myc downstream-regulated gene 2 (NDRG2) self-amplifying mRNA via modified lipid nanoparticles as a potential treatment for drug-resistant and metastatic cancersSandra E Reznik, Amit K Tiwari, Vivek Chavda, et al.
Synapse (New York, N.Y.)|September 30, 2003
Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Lee Schechter, Kenji Hashimoto, et al.
European Journal of Pharmacology|December 27, 1991
The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cellsY Minabe, C R Ashby, J E Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2013
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compoundsBhargav A Patel, Charles R Ashby, Diane Hardej, et al.
Pageof 32

Showing results (71-80 of 320) with videos related to

Sort By:
Pageof 32
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 3, 2015
The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decadeRishil J Kathawala, Pranav Gupta, Charles R Ashby, et al.
The Journal of Clinical Psychiatry|September 1, 1994
The role of 5-HT3-like receptors in the action of clozapineR Y Wang, C R Ashby, E Edwards, et al.
European Journal of Pharmacology|July 16, 1997
Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis studyA E Morgan, B Horan, S L Dewey, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 16, 2019
Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance HemodialysisAnamika Adwaney, Charlotte Lim, Sarah Blakey, et al.
Neuroscience|May 1, 1994
The induction of serotonin3-like receptor supersensitivity and dopamine receptor subsensitivity in the rat medial prefrontal cortex after the intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine: a microiontophoretic studyC R Ashby, J Y Zhang, E Edwards, et al.
Clinical Nephrology|March 28, 2022
Diagnostic value of pericardial aspiration in dialysis patients: Case report with management informed by a retrospective case seriesAmarpreet K Thind, Sophie Blackburn, Richard W Corbett, et al.
Medical Review (2021)|June 26, 2024
The delivery of N-myc downstream-regulated gene 2 (NDRG2) self-amplifying mRNA via modified lipid nanoparticles as a potential treatment for drug-resistant and metastatic cancersSandra E Reznik, Amit K Tiwari, Vivek Chavda, et al.
Synapse (New York, N.Y.)|September 30, 2003
Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Lee Schechter, Kenji Hashimoto, et al.
European Journal of Pharmacology|December 27, 1991
The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cellsY Minabe, C R Ashby, J E Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2013
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compoundsBhargav A Patel, Charles R Ashby, Diane Hardej, et al.
Pageof 32